Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Forecast calculations
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Radiofrequency ablation devices industry 360° synopsis, 2018 - 2032
2.2 Business trends
2.3 Regional trends (Revenue & Volume)
2.4 Product type trends (Revenue & Volume)
2.5 Application trends
2.6 End-use trends
Chapter 3 Radiofrequency Ablation Devices Industry Insights
3.1 Impact on COVID-19
3.2 Industry ecosystem analysis
3.3 Technology & innovation landscape
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increasing preference for minimally invasive procedures
3.5.1.2 Growing prevalence of chronic diseases
3.5.1.3 Technological advancements in RF ablation devices
3.5.1.4 Growing geriatric population base
3.5.2 Industry pitfalls & challenges
3.5.2.1 Low awareness and availability of alternative treatment methods
3.5.2.2 High treatment cost
3.6 Growth potential analysis
3.6.1 By product type
3.6.2 By application
3.6.3 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company market share, 2022
4.3 Competitive analysis of major market players, 2022
4.3.1 Abbott Laboratories, Inc.
4.3.2 Medtronic, Plc.
4.3.3 Boston Scientific Corporation
4.4 Competitive positioning matrix, 2022
4.5 Strategic outlook matrix, 2022
Chapter 5 Radiofrequency Ablation Devices Market Estimates and Forecast, By Product Type (Revenue & Volume)
5.1 Key trends, by product type
5.2 RF generators
5.3 Consumables
Chapter 6 Radiofrequency Ablation Devices Market Estimates and Forecast, By Application (Revenue)
6.1 Key trends, by application
6.2 Oncology
6.3 Cardiology
6.4 Cosmetic surgery
6.5 Gynecology
6.6 Pain management
6.7 Urology
6.8 Others
Chapter 7 Radiofrequency Ablation Devices Market Estimates and Forecast, By End-use (Revenue)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Others
Chapter 8 Radiofrequency Ablation Devices Market Estimates and Forecast, By Region (Revenue & Volume)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Switzerland
8.3.7 The Netherlands
8.3.8 Denmark
8.3.9 Poland
8.3.10 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 New Zealand
8.4.7 Vietnam
8.4.8 Indonesia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Turkey
Chapter 9 Company Profiles
9.1 Avanos Medical, Inc.
9.2 Stryker Corporation
9.3 Abbott Laboratories, Inc.
9.4 Medtronic, Plc.
9.5 Boston Scientific Corporation
9.6 Becton, Dickinson and Company (Venclose, Inc.)
9.7 AngioDynamics, Inc.
9.8 Hologic, Inc.
9.9 AtriCure, Inc.
9.10 Koninklijke Philips N.V.
9.11 Smith & Nephew
9.12 Baylis Medical Company, Inc
9.13 inomed Medizintechnik GmbH
9.14 Sutter Medizintechnik GmbH
9.15 Epimed International
